AVIENCE — Avience Biomedicals Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹1.37bn
- IN₹1.61bn
- IN₹525.06m
Annual cashflow statement for Avience Biomedicals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | C2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 9.62 | 9.59 | 29.5 | 97.7 | 125 |
| Depreciation | |||||
| Non-Cash Items | 1.61 | 2.63 | 8.42 | 14.1 | 15 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -31.8 | 1.56 | -34.2 | -86.6 | -92.8 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -19.6 | 15.9 | 9.85 | 33.9 | 59.1 |
| Capital Expenditures | -8.69 | -16.9 | -38.8 | -93 | -134 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.177 | -2.48 | -1.47 | -2.41 | 1.79 |
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -8.86 | -19.4 | -40.3 | -95.4 | -133 |
| Financing Cash Flow Items | -1.47 | -2.36 | -7.83 | -13.5 | -13.6 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 27.9 | 4.33 | 29.7 | 102 | 54.2 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.63 | 0.839 | -0.756 | 40.6 | -19.5 |